These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study). Antonelli A; Palumbo C; Noale M; Porreca A; Maggi S; Simeone C; Bassi P; Bertoni F; Bracarda S; Buglione M; Conti GN; Corvò R; Gacci M; Mirone V; Montironi R; Triggiani L; Tubaro A; Artibani W; Urol Int; 2019; 103(1):8-18. PubMed ID: 30731456 [TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy. Jayadevappa R; Chhatre S; Whittington R; Bloom BS; Wein AJ; Malkowicz SB BJU Int; 2006 May; 97(5):955-62. PubMed ID: 16643477 [TBL] [Abstract][Full Text] [Related]
5. Responsiveness of the University of California-Los Angeles Prostate Cancer Index. Bergman J; Saigal CS; Kwan L; Litwin MS Urology; 2010 Jun; 75(6):1418-23. PubMed ID: 19589573 [TBL] [Abstract][Full Text] [Related]
6. The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR Study. Gacci M; Greco I; Artibani W; Bassi P; Bertoni F; Bracarda S; Briganti A; Carmignani G; Carmignani L; Conti GN; Corvò R; DE Nunzio C; Fusco F; Graziotti P; Maggi S; Magrini SM; Mirone V; Montironi R; Muto G; Noale M; Pecoraro S; Porreca A; Ricardi U; Russi E; Salonia A; Simonato A; Serni S; Tubaro A; Zagonel V; Crepaldi G; Minerva Urol Nephrol; 2022 Feb; 74(1):38-48. PubMed ID: 33200896 [TBL] [Abstract][Full Text] [Related]
7. Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR). Buglione M; Noale M; Bruni A; Antonelli A; Bertoni F; Corvo' R; Ricardi U; Borghetti P; Maddalo M; Simeone C; Mazzeo E; Porreca A; Serni S; Bassi P; Gacci M; Mirone V; Montironi R; Tubaro A; Berruti A; Conti GN; Maggi S; Magrini SM; Triggiani L; PLoS One; 2019; 14(11):e0224151. PubMed ID: 31675380 [TBL] [Abstract][Full Text] [Related]
8. Quality of life after radical treatment of prostate cancer: validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index. Gacci M; Livi L; Paiar F; Detti B; Litwin MS; Bartoletti R; Giubilei G; Cai T; Mariani M; Carini M Urology; 2005 Aug; 66(2):338-43. PubMed ID: 16098363 [TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study. Palumbo C; Bruni A; Antonelli A; Artibani W; Bassi P; Bertoni F; Borghetti P; Bracarda S; Cicchetti A; Corvò R; Gacci M; Ingrosso G; Magrini SM; Maruzzo M; Mirone V; Montironi R; Muto G; Noale M; Porreca A; Russi E; Triggiani L; Tubaro A; Valdagni R; Maggi S; Conti GN; Minerva Urol Nephrol; 2022 Feb; 74(1):11-20. PubMed ID: 33439570 [TBL] [Abstract][Full Text] [Related]
10. Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study). Antonelli A; Palumbo C; Noale M; Artibani W; Bassi P; Bertoni F; Bracarda S; Bruni A; Corvò R; Gacci M; Magrini SM; Montironi R; Porreca A; Tubaro A; Zagonel V; Maggi S; Minerva Urol Nefrol; 2020 Oct; 72(5):595-604. PubMed ID: 31920063 [TBL] [Abstract][Full Text] [Related]
11. Analysis linking UCLA PCI with Expanded Prostate Cancer Index Composite: an evaluation of health related quality of life in Japanese men with localized prostate cancer. Namiki S; Takegami M; Kakehi Y; Suzukamo Y; Fukuhara S; Arai Y J Urol; 2007 Aug; 178(2):473-7; discussion 477. PubMed ID: 17561164 [TBL] [Abstract][Full Text] [Related]
12. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life. Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KN; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL; BJU Int; 2016 Dec; 118(6):869-879. PubMed ID: 27415448 [TBL] [Abstract][Full Text] [Related]
13. The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients. Bacon CG; Giovannucci E; Testa M; Glass TA; Kawachi I Cancer; 2002 Feb; 94(3):862-71. PubMed ID: 11857323 [TBL] [Abstract][Full Text] [Related]
14. Impact of Gastrointestinal Side Effects on Patients' Reported Quality of Life Trajectories after Radiotherapy for Prostate Cancer: Data from the Prospective, Observational Pros-IT CNR Study. Noale M; Bruni A; Triggiani L; Buglione M; Bertoni F; Frassinelli L; Montironi R; Corvò R; Zagonel V; Porreca A; Bassi P; Gacci M; Conti GN; Maggi S; Magrini S; The Pros-It Cnr Study Group Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33806994 [TBL] [Abstract][Full Text] [Related]
15. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial. Vasarainen H; Lokman U; Ruutu M; Taari K; Rannikko A BJU Int; 2012 Jun; 109(11):1614-9. PubMed ID: 22044485 [TBL] [Abstract][Full Text] [Related]
16. Prospective longitudinal comparative study of early health-related quality-of-life outcomes in patients undergoing surgical treatment for localized prostate cancer: a short-term evaluation of five approaches from a single institution. Ball AJ; Gambill B; Fabrizio MD; Davis JW; Given RW; Lynch DF; Shaves M; Schellhammer PF J Endourol; 2006 Oct; 20(10):723-31. PubMed ID: 17094746 [TBL] [Abstract][Full Text] [Related]
17. Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer. Lemanska A; Dearnaley DP; Jena R; Sydes MR; Faithfull S Clin Oncol (R Coll Radiol); 2018 Jun; 30(6):334-345. PubMed ID: 29459102 [TBL] [Abstract][Full Text] [Related]
18. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial. Denham JW; Wilcox C; Joseph D; Spry NA; Lamb DS; Tai KH; Matthews J; Atkinson C; Turner S; Christie D; Gogna NK; Kenny L; Duchesne G; Delahunt B; McElduff P Lancet Oncol; 2012 Dec; 13(12):1260-70. PubMed ID: 23151431 [TBL] [Abstract][Full Text] [Related]
19. How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study. Gacci M; Artibani W; Bassi P; Bertoni F; Bracarda S; Briganti A; Carmignani G; Carmignani L; Conti G; Corvò R; De Nunzio C; Fusco F; Graziotti P; Greco I; Maggi S; Magrini SM; Mirone V; Montironi R; Morgia G; Muto G; Noale M; Pecoraro S; Porreca A; Ricardi U; Russi E; Russo G; Salonia A; Simonato A; Serni S; Tomasini D; Tubaro A; Zagonel V; Crepaldi G; World J Urol; 2021 May; 39(5):1445-1452. PubMed ID: 32740803 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of health-related quality of life in patients with prostate cancer after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy. Dragićević S; Naumović T; Soldatović I; Mićić S; Tulić C; Pekmezović T Urol Int; 2010; 85(2):173-179. PubMed ID: 20606405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]